In addition, studies on CDCA7 have found that its high expression can help to predict poor prognosis and tumor progression in colorectal carcinoma and kidney carcinoma (Li et al., 2020; Liu et al., 2021). This evidence concerns the gene CDCA7 and neoplasm.